Why Apple Watch Sales Could Soar With This FDA Plan in Action (AAPL)
Apple Inc.’s (NASDAQ:AAPL) Apple Watch has been what is probably best described as a modest success. A new initiative from the Food and Drug Administration could change that, by making it easier to certify digital health devices. The FDA move could pave the way for the rumored Apple Watch for diabetics, blowing open the market for AAPL’s smartwatch from tech early adopters to hundreds of millions of people in need of blood glucose monitoring.
Source:: https://finance.yahoo.com/news/why-apple-watch-sales-could-134356583.html
